Article
Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development.
Bioorganic & medicinal chemistry - 1 May 2011
Su Jing, Wang Qiang, Feng Jinhong, Zhang Cong, Zhu Deyu, Wei Tiandi, Xu Wenfang, Gu Lichuan
Abstract excerpt
Human aminopeptidase N (hAPN) is an appealing objective for the development of anti-cancer agents. The absence of mammalian APN experimental structure negatively impinges upon the progression of structure-based drug design. Tricorn interacting factor F3 (factor F3) from Thermoplasma acidophilum shares 33% sequence identity with hAPN. Engineered factor F3 with two point directed mutations resulted in a protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
